Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
DNAJC21 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
HSF2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SRSF3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SNX6 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
FBXO5 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MOCS2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TEP1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ARMT1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
UBE2B - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
YWHAB - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
YTHDF3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TNRC6B - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PEX3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MEX3C - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SNRPD1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
STIL - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CHMP2B - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
FECH - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
RASSF3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on